NCT00207311 Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus Status COMPLETED Phase PHASE4
NCT00206076 Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation Status COMPLETED Phase PHASE4
NCT00204659 Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00199732 Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a Status COMPLETED Phase N/A
NCT00199719 Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM Status COMPLETED Phase PHASE2
NCT00199667 Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients Status UNKNOWN Phase PHASE4
NCT00198224 Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients Status COMPLETED Phase NA
NCT00196638 Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection Status TERMINATED Phase PHASE2/PHASE3
NCT00196586 Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients Status COMPLETED Phase PHASE2
NCT00194727 Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00193635 Pilot Study of Mycophenolate Mofetil in Congenital Uropathies Status COMPLETED Phase PHASE1
NCT00192647 A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection Status COMPLETED Phase PHASE4
NCT00192608 A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study Status COMPLETED Phase NA
NCT00189579 Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer Status TERMINATED Phase PHASE2